ST. LOUIS — A study by the Washington University School of Medicine and the VA St. Louis Health Care System has uncovered both widespread health benefits and risks associated with GLP-1 drugs commonly ...
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results